App helps patients, caregivers monitor anticoagulant therapy

ClotMD can improve adherence to drug orders, reduce trips to outpatient settings.


A new SaaS-based application will let patients turn their homes into virtual coagulation clinics.

ClotMD, which can be accessed from a desktop or mobile device, connects patients on anticoagulation medicine with their providers for real-time communication.

“Each person, whether it’s a physician, patient or nurse, has their own profile on how they want to be contacted,” says Patricia Lyons-Blum, ClotMD’s director of business development.



The app enables providers to see when patients are outside of their target therapeutic ranges or are non-compliant with prescribed medication or testing. Providers also get real-time alerts on INR levels, scheduled testing and dosing calculations.

The provider is asked initially to input a patient’s information into the app’s customizable algorithm for later use and reference, says Lyons-Blum. This can include age, gender, disease type, and medicine type and dosage. The algorithm originally was created by parent company BBMK Technologies for a similar sleep apnea app,

Patients can track and share their history of current and previous INR levels with the provider, along with access to a built-in diet library to encourage a healthy lifestyle. Patients also will receive automatic notifications about dosage changes, which require them to confirm they read and understood the message.

If a patient is non-compliant, the provider can call and follow up to avoid non-adherence, which costs the healthcare industry from $100 billion to $300 billion each year, according to the IMS Institute for Healthcare Informatics.

Beyond non-adherence costs, Lyons-Blum says ClotMD could help minimize provider costs because patients will not have to be sent to coagulation clinics. Although Lyons-Blum estimates 100,000 providers will use the recently launched app, there are some challenges.

The app is meant to help improve the health outcomes of patients who are taking coagulation medication, and those in that target audience tend to be older and forgetful, she says. However, those patients also tend to not be as tech savvy as other populations, she says. As a result, it may be more effective for caregivers to use the app on behalf of their patients.

More for you

Loading data for hdm_tax_topic #better-outcomes...